Kratos (KTOS) Lifts Guidance and Advances Engine Tech—Is Its Competitive Edge in Defense Widening?

Kratos Defense & Security Solutions, Inc. -3.58%

Kratos Defense & Security Solutions, Inc.

KTOS

75.96

-3.58%

  • Last week, Kratos Defense & Security Solutions raised its full-year 2025 and 2026 guidance, reported third-quarter results showing higher revenue and net income, and announced significant progress in its engine technology collaboration with GE Aerospace.
  • This combination of improved financial outlook and tangible advancement in unmanned aerial systems propulsion highlights both operational momentum and the strengthening of Kratos' position within the defense technology sector.
  • We'll examine how Kratos' upward revision to earnings guidance and successful engine testing may influence its investment outlook and growth trajectory.

Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

Kratos Defense & Security Solutions Investment Narrative Recap

To be a shareholder in Kratos Defense & Security Solutions, you need to have conviction in its ability to capitalize on long-term defense spending tailwinds, particularly in unmanned systems and propulsion technologies. The recent improvement in financial guidance and progress with GE Aerospace strengthen the company’s operational momentum, but do not eliminate the most important short-term risk: heavy upfront investment that outpaces secured contract awards, which could still impact margins and free cash flow if programs are delayed. Of all recent developments, the successful altitude and durability testing of the GEK800 engine with GE Aerospace stands out. This tangible milestone supports one of Kratos’ main growth drivers, the push to expand its unmanned aerial systems business and move innovative products toward production, potentially accelerating contract wins and revenue realization in a defense market eager for cutting-edge propulsion solutions. Yet, despite clear traction in technology development, one risk in particular that investors should be aware of is the exposure to delays in contract awards and the knock-on effects for liquidity...

Kratos Defense & Security Solutions' narrative projects $1.9 billion in revenue and $101.6 million in earnings by 2028. This requires 17.0% yearly revenue growth and an $87.1 million increase in earnings from the current $14.5 million.

Uncover how Kratos Defense & Security Solutions' forecasts yield a $100.00 fair value, a 31% upside to its current price.

Exploring Other Perspectives

KTOS Community Fair Values as at Nov 2025
KTOS Community Fair Values as at Nov 2025

The Simply Wall St Community’s 13 fair value estimates for Kratos range widely from US$4.19 to US$100 per share. While many see growth ahead, the ongoing need for substantial capital outlays and timely contract conversions remains a key factor that could shape future results. Check out how your assessment compares and why views can differ so much.

Explore 13 other fair value estimates on Kratos Defense & Security Solutions - why the stock might be worth less than half the current price!

Build Your Own Kratos Defense & Security Solutions Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Kratos Defense & Security Solutions research is our analysis highlighting 3 key rewards that could impact your investment decision.
  • Our free Kratos Defense & Security Solutions research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Kratos Defense & Security Solutions' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

  • Outshine the giants: these 25 early-stage AI stocks could fund your retirement.
  • These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
  • AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via